 CHATHAM, N.J., April 21, 2021 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP Tonix or the Company a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, was invited to deliver a company presentation and participate in a panel at the 4th Annual Neuroscience Innovation Forum for Business Development, Licensing and Investment, hosted by Sachs Associates and taking place from April 28-30, 2021. 